Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Our Impact

The Bionics Institute has a strong history of developing medical devices to improve the lives of people with challenging medical conditions.

The Bionics Institute has long been at the forefront of translating medical device concepts into clinical reality, dating back to 1986 when it was founded by Professor Graeme Clark.

Professor Clark led the team that created Australiaʼs cochlear implant, commercialised by Cochlear Pty Ltd. Since then, Bionics Institute researchers have developed:

Australiaʼs first-generation bionic eye prototype implanted in clinical trials in 2018, and commercialised by Bionic Vision Technologies.

The epilepsy seizure monitoring device, commercialised by Bionics Institute spin-off company Epi-Minder Pty Ltd.

An adaptive deep brain stimulation system for Parkinsonʼs disease, commercialised by Bionics Institute spin-off Deep Brain Stimulation Technologies Pty Ltd (DBS Tech)

An innovative vagus nerve stimulation device to treat inflammatory bowel disease, which is moving into clinical trials and also being adapted to treat rheumatoid arthritis and diabetes.

Novel drug delivery methods for hearing loss; new diagnostic tools for improved diagnosis of infant hearing and tinnitus; and research to improve cochlear implants.


In 2021, we launched spin-off company Neo-Bionica, a joint initiative of the Bionics Institute and the University of Melbourne, which combines the engineering expertise and state-of-the-art facilities needed to develop medical devices from initial concept to first-in-human prototypes for clinical trials.

Research Articles

Subscribe for the latest news